Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Feb 13;98(4):1601-6.
doi: 10.1073/pnas.98.4.1601. Epub 2001 Feb 6.

beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking

T A Kohout  1 , F S Lin, S J Perry, D A Conner, R J Lefkowitz
Affiliations

beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking

T A Kohout et al. Proc Natl Acad Sci U S A. .

Abstract

The two widely coexpressed isoforms of beta-arrestin (termed beta arrestin 1 and 2) are highly similar in amino acid sequence. The beta-arrestins bind phosphorylated heptahelical receptors to desensitize and target them to clathrin-coated pits for endocytosis. To better define differences in the roles of beta-arrestin 1 and 2, we prepared mouse embryonic fibroblasts from knockout mice that lack one of the beta-arrestins (beta arr1-KO and beta arr2-KO) or both (beta arr1/2-KO), as well as their wild-type (WT) littermate controls. These cells were analyzed for their ability to support desensitization and sequestration of the beta(2)-adrenergic receptor (beta(2)-AR) and the angiotensin II type 1A receptor (AT(1A)-R). Both beta arr1-KO and beta arr2-KO cells showed similar impairment in agonist-stimulated beta(2)-AR and AT(1A)-R desensitization, when compared with their WT control cells, and the beta arr1/2-KO cells were even further impaired. Sequestration of the beta(2)-AR in the beta arr2-KO cells was compromised significantly (87% reduction), whereas in the beta arr1-KO cells it was not. Agonist-stimulated internalization of the AT(1A)-R was only slightly reduced in the beta arr1-KO but was unaffected in the beta arr2-KO cells. In the beta arr1/2-KO cells, the sequestration of both receptors was dramatically reduced. Comparison of the ability of the two beta-arrestins to sequester the beta(2)-AR revealed beta-arrestin 2 to be 100-fold more potent than beta-arrestin 1. Down-regulation of the beta(2)-AR was also prevented in the beta arr1/2-KO cells, whereas no change was observed in the single knockout cells. These findings suggest that sequestration of various heptahelical receptors is regulated differently by the two beta-arrestins, whereas both isoforms are capable of supporting receptor desensitization and down-regulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analysis of β-arrestin expression in MEF cell lines. Whole cell lysates were prepared from 11 MEF cell lines and resolved (50–70 μg of protein per lane) by SDS/PAGE. Proteins were transferred to a nitrocellulose sheet and immunoblotted with the polyclonal anti-β-arrestin antibody A1CT. The genotype of each MEF line is described beneath the immunoblot. Lines 1–5 are littermates of a βarr2(+/−) × βarr2(+/−) cross, lines 6–9 are littermates from a βarr1(+/−) × βarr1(+/−) cross, and lines 10 and 11 are littermates from a βarr1(+/−) βarr2(−/−) × βarr1(−/−) βarr2(+/−) cross.
Figure 2
Figure 2
Quantitation of β-arrestin levels in MEF cell lines. (A) Whole cell lysates (50 μg) from WT (line 1), βarr1-KO (line 6), and βarr2-KO (line 2) (Left) and known quantities of β-arrestin1-Flag and β-arrestin2-Flag proteins (Right) were separated by SDS/PAGE, transferred to nitrocellulose, and immunoblotted with the A1CT antibody. (B) Concentrations of β-arrestin 1 and β-arrestin 2 in the above MEF lines were quantitated by densitometric analysis of the immunoblots. The resulting β-arrestin levels are plotted as ng of β-arrestin per mg of cell protein. Data are expressed as the mean ± SEM of four to seven experiments.
Figure 3
Figure 3
Effect of reduced β-arrestin levels on second messenger generation. (A and B) Littermate WT (line 8) and βarr1-KO (line 6) cell lines (A) or littermate WT (line 1) and βarr2-KO (line 2) cell lines (B), as well as the βarr1/2-KO cell line 10, all expressing approximately100 fmol of β2-AR per mg of protein, were stimulated with 10 μM isoproterenol as indicated. Isoproterenol-induced cAMP accumulation in the MEF lines was determined as the percent conversion of [3H]adenine into [3H]cAMP and then normalized to total forskolin (50 μM)-stimulated cAMP accumulation for each cell line. Data are the mean ± SEM of three to six experiments and were analyzed with GRAPHPAD PRISM software. (C) WT (line 1), βarr1-KO (line 6), βarr2-KO (line 2), and βarr1/2-KO (line 10) MEF cell lines, all expressing AT1A-R at 200–350 fmol/mg of protein, were stimulated with 100 nM AngII for the indicated times. Accumulation of inositol phosphates was measured as the fold difference over basal accumulation. Data are the mean ± SEM of 10 experiments. Unpaired, two-tailed t tests were performed for total cAMP and total inositol phosphate accumulations between WT and βarr1-KO, βarr2-KO, or βarr1/2-KO lines (*, P < 0.005) and between βarr1/2-KO and βarr1-KO or βarr2-KO lines (†, P < 0.03).
Figure 4
Figure 4
Effect of reduced levels of β-arrestins on heptahelical receptor sequestration. (A) Littermate MEF βarr2-KO lines 1–5, βarr1-KO lines 6–9, and βarr1/2-KO lines 10 and 11 expressing 200–300 fmol of β2-AR per mg of protein were stimulated with 10 μM isoproterenol (iso) for 20 min at 37°C. Receptor sequestration was subsequently measured with a ligand binding assay. Percent isoproterenol-stimulated sequestration was determined as the difference between the agonist-stimulated internalized β2-ARs and the nonstimulated basally internalized β2-ARs. (B) Littermate MEF βarr2-KO lines 1–5, βarr1-KO lines 6–9, and βarr1/2-KO lines 10 and 11 expressing 200–350 fmol of AT1A-R per mg of protein were stimulated with 0.2 nM 125I-labeled AngII for 20 min at 37°C. Percent AngII-stimulated sequestration was determined as acid-resistant cpm divided by the total cpm bound. Data are the mean ± SEM of 5–10 experiments. An unpaired two-tailed t test was used to test statistical significance. *, P < 0.0001 between βarr2-KO (lines 2–4) cell lines and their WT controls (lines 1 and 5); †, P < 0.01 between βarr1-KO (lines 6 and 7) cell lines and their WT control (lines 8 and 9); **, P < 0.0001 between βarr1/2-KO (lines 10 and 11) cell lines and all WT lines (lines 1, 5, 8, and 9).
Figure 5
Figure 5
Reconstitution of agonist-induced β2-AR sequestration by β-arrestin 1 or 2 in βarr1/2-KO MEFs. (A and B) βarr1/2-KO cells (line 10) were infected with various multiplicities of infection of βarr1-Ad (A) or βarr2-Ad (B) and sufficient β2-AR Ad to express β2-AR at approximately 200 fmol/mg. The level of β-arrestin expression in each infection was determined by Western blotting of cell lysates (Upper) followed by comparison to a standard curve of β-arrestin1-Flag and β-arrestin2-Flag proteins. Isoproterenol-induced β2-AR sequestration for each infection was then determined (Lower). A and B show a representative experiment (n = 5). For comparison, the same protein concentration from WT cell lysates was immunoblotted and its isoproterenol-induced sequestration is represented as a dashed line in the bar graph. (C) Pooled data from all experiments showing effect of β-arrestin expression on the ability of βarr1/2-KO cells to sequester the β2-AR.
Figure 6
Figure 6
Effect of reduced β-arrestin expression on down-regulation of the β2-AR. WT (line 1), βarr1-KO (line 6), βarr2-KO (line 2), and βarr1/2-KO (line 10) cell lines expressing β2-AR at approximately 150 fmol/mg of protein or endogenous β2-AR (approximately 25–50 fmol/mg of protein) were stimulated with 10 μM isoproterenol as indicated. Experiments with overexpressed β2-AR (n = 3) and with endogenous β2-AR (n = 4) showed similar results, and thus data were pooled. Receptor number was determined by ligand binding. An unpaired two-tailed t test was used to determine statistical significance as follows. *, P < 0.01 between WT and βarr1/2-KO cells.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pitcher J A, Freedman N J, Lefkowitz R J. Annu Rev Biochem. 1998;67:653–692. - PubMed
    1. Lefkowitz R J. J Biol Chem. 1998;273:18677–18680. - PubMed
    1. Laporte S A, Oakley R H, Zhang J, Holt J A, Ferguson S S, Caron M G, Barak L S. Proc Natl Acad Sci USA. 1999;96:3712–3717. - PMC - PubMed
    1. Goodman O B, Jr, Krupnick J G, Santini F, Gurevich V V, Penn R B, Gagnon A W, Keen J H, Benovic J L. Nature (London) 1996;383:447–450. - PubMed
    1. McDonald P H, Cote N L, Lin F T, Premont R T, Pitcher J A, Lefkowitz R J. J Biol Chem. 1999;274:10677–10680. - PubMed

Publication types

MeSH terms